349 related articles for article (PubMed ID: 34042325)
1. Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?
Orvain C; Boulch M; Bousso P; Allanore Y; Avouac J
Arthritis Rheumatol; 2021 Nov; 73(11):1954-1965. PubMed ID: 34042325
[TBL] [Abstract][Full Text] [Related]
2. Dawn of CAR-T cell therapy in autoimmune diseases.
Liu Y; Dong M; Chu Y; Zhou L; You Y; Pang X; Yang S; Zhang L; Chen L; Zhu L; Xiao J; Wang W; Qin C; Tian D
Chin Med J (Engl); 2024 May; 137(10):1140-1150. PubMed ID: 38613216
[TBL] [Abstract][Full Text] [Related]
3. Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease.
Daamen AR; Lipsky PE
Ann Rheum Dis; 2024 May; 83(6):696-699. PubMed ID: 38637134
[TBL] [Abstract][Full Text] [Related]
4. CAR T-cell therapy in autoimmune diseases.
Schett G; Mackensen A; Mougiakakos D
Lancet; 2023 Nov; 402(10416):2034-2044. PubMed ID: 37748491
[TBL] [Abstract][Full Text] [Related]
5. CD8
Whittington KB; Prislovsky A; Beaty J; Albritton L; Radic M; Rosloniec EF
J Immunol; 2022 Jan; 208(1):16-26. PubMed ID: 34819392
[TBL] [Abstract][Full Text] [Related]
6. Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?
Santamaria-Alza Y; Vasquez G
Inflamm Res; 2021 Jun; 70(6):651-663. PubMed ID: 34018005
[TBL] [Abstract][Full Text] [Related]
7. Chimeric antigen receptor T-cell therapy beyond cancer: current practice and future prospects.
Zhang PF; Xie D; Li Q
Immunotherapy; 2020 Sep; 12(13):1021-1034. PubMed ID: 32727249
[TBL] [Abstract][Full Text] [Related]
8. Autoimmunity as a target for chimeric immune receptor therapy: A new vision to therapeutic potential.
Haddadi MH; Hajizadeh-Saffar E; Khosravi-Maharlooei M; Basiri M; Negahdari B; Baharvand H
Blood Rev; 2020 May; 41():100645. PubMed ID: 31813654
[TBL] [Abstract][Full Text] [Related]
9. CAR T cells for treating autoimmune diseases.
Blache U; Tretbar S; Koehl U; Mougiakakos D; Fricke S
RMD Open; 2023 Nov; 9(4):. PubMed ID: 37996128
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells.
Elahi R; Khosh E; Tahmasebi S; Esmaeilzadeh A
Front Immunol; 2018; 9():1717. PubMed ID: 30108584
[TBL] [Abstract][Full Text] [Related]
11. CAR T cells for infection, autoimmunity and allotransplantation.
Maldini CR; Ellis GI; Riley JL
Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases.
Chen Y; Sun J; Liu H; Yin G; Xie Q
J Immunol Res; 2019; 2019():5727516. PubMed ID: 32083141
[TBL] [Abstract][Full Text] [Related]
13. Chimeric antigen receptor-engineered T-cell therapy for liver cancer.
Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW
Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325
[TBL] [Abstract][Full Text] [Related]
14. Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy.
Han X; Wang Y; Wei J; Han W
J Hematol Oncol; 2019 Nov; 12(1):128. PubMed ID: 31783889
[TBL] [Abstract][Full Text] [Related]
15. Application of CAR-T cell technology in autoimmune diseases and human immunodeficiency virus infection treatment.
Adabi N; Pordel S; Rezaee MA; Shobeiri FS; Shobeiri SS
J Gene Med; 2023 May; 25(5):e3484. PubMed ID: 36781390
[TBL] [Abstract][Full Text] [Related]
16. Prospects for CAR T cell immunotherapy in autoimmune diseases: clues from Lupus.
Radic M; Neeli I; Marion T
Expert Opin Biol Ther; 2022 Apr; 22(4):499-507. PubMed ID: 35089116
[TBL] [Abstract][Full Text] [Related]
17. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy.
Ghassemi S; Milone MC
J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011
[TBL] [Abstract][Full Text] [Related]
18. The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells.
Hughes-Parry HE; Cross RS; Jenkins MR
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31892219
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of T cells with chimeric antigen receptors for hematological malignancy immunotherapy.
Ti D; Niu Y; Wu Z; Fu X; Han W
Sci China Life Sci; 2018 Nov; 61(11):1320-1332. PubMed ID: 30414005
[TBL] [Abstract][Full Text] [Related]
20. CAR T-Cell Therapy in Hematological Malignancies.
Haslauer T; Greil R; Zaborsky N; Geisberger R
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
